[HTML][HTML] Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
S Zhang, J Shen, D Li, Y Cheng - Theranostics, 2021 - ncbi.nlm.nih.gov
CRISPR/Cas9 genome editing has gained rapidly increasing attentions in recent years,
however, the translation of this biotechnology into therapy has been hindered by efficient …
however, the translation of this biotechnology into therapy has been hindered by efficient …
DNA hydrogel-based gene editing and drug delivery systems
Deoxyribonucleic acid (DNA) is a promising synthesizer for precisely constructing almost
arbitrary geometry in two and three dimensions. Among various DNA-based soft materials …
arbitrary geometry in two and three dimensions. Among various DNA-based soft materials …
DNA hydrogels and microgels for biosensing and biomedical applications
F Li, D Lyu, S Liu, W Guo - Advanced Materials, 2020 - Wiley Online Library
DNA hydrogels, which take advantage of the unique properties of functional DNA motifs,
such as specific molecular recognition, programmable and high‐precision assembly …
such as specific molecular recognition, programmable and high‐precision assembly …
Rolling circle replication for biosensing, bioimaging, and biomedicine
S Yue, Y Li, Z Qiao, W Song, S Bi - Trends in Biotechnology, 2021 - cell.com
Rolling circle replication (RCR), including rolling circle amplification (RCA) and rolling circle
transcription (RCT), is an isothermal enzymatic reaction. Because of its high amplification …
transcription (RCT), is an isothermal enzymatic reaction. Because of its high amplification …
[HTML][HTML] Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis
M Zhao, R Wang, K Yang, Y Jiang, Y Peng, Y Li… - … Pharmaceutica Sinica B, 2023 - Elsevier
RNAs are involved in the crucial processes of disease progression and have emerged as
powerful therapeutic targets and diagnostic biomarkers. However, efficient delivery of …
powerful therapeutic targets and diagnostic biomarkers. However, efficient delivery of …
Cation‐free siRNA micelles as effective drug delivery platform and potent RNAi nanomedicines for glioblastoma therapy
T Jiang, Y Qiao, W Ruan, D Zhang, Q Yang… - Advanced …, 2021 - Wiley Online Library
Nanoparticle‐based small interfering RNA (siRNA) therapy shows great promise for
glioblastoma (GBM). However, charge associated toxicity and limited blood–brain‐barrier …
glioblastoma (GBM). However, charge associated toxicity and limited blood–brain‐barrier …
Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
G Mahmoodi Chalbatani, H Dana… - International journal …, 2019 - Taylor & Francis
Cancer is one of the most complex diseases that has resulted in multiple genetic disorders
and cellular abnormalities. Globally, cancer is the most common health concern disease that …
and cellular abnormalities. Globally, cancer is the most common health concern disease that …
Synthetic materials at the forefront of gene delivery
I Lostalé-Seijo, J Montenegro - Nature Reviews Chemistry, 2018 - nature.com
The delivery of nucleic acids with transient activity for genetic engineering is a promising
methodology with potential applications in the treatment of diseases ranging from cancer …
methodology with potential applications in the treatment of diseases ranging from cancer …
ROS‐responsive polymeric siRNA nanomedicine stabilized by triple interactions for the robust glioblastoma combinational RNAi therapy
Small interfering RNA (siRNA) holds inherent advantages and great potential for treating
refractory diseases. However, lack of suitable siRNA delivery systems that demonstrate …
refractory diseases. However, lack of suitable siRNA delivery systems that demonstrate …
[HTML][HTML] Applications and developments of gene therapy drug delivery systems for genetic diseases
X Pan, H Veroniaina, N Su, K Sha, F Jiang… - Asian journal of …, 2021 - Elsevier
Genetic diseases seriously threaten human health and have always been one of the
refractory conditions facing humanity. Currently, gene therapy drugs such as siRNA, shRNA …
refractory conditions facing humanity. Currently, gene therapy drugs such as siRNA, shRNA …